Loading...
Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer
PURPOSE: Cisplatin-associated arterial and venous thromboembolic events (TEEs) are becoming an increasing concern. In patients with small-cell lung cancer (SCLC) who are treated using cisplatin-based chemotherapy, we assume that the overall risk of TEEs is high. However, cisplatin-associated vascula...
Na minha lista:
| Udgivet i: | Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Cancer Association
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4614217/ https://ncbi.nlm.nih.gov/pubmed/25672586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.045 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|